VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
HIPEC with Carboplatin
Phase 2
Small molecule
W
Wake Forest University Health Sciences
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Ovarian Epithelial Cancer
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Ovarian Epithelial Cancer
Phase 2
Completed
Clinical
Trials by Indication
[1]
Ovarian Epithelial Cancer
1 trial
A Phase II Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With HIPEC in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
Completed
·
W
Wake Forest University Health Sciences
·
Phase 2
·
NCT04415944
·
10 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for HIPEC with Carboplatin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
HIPEC with Carboplatin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for HIPEC with Carboplatin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Wake Forest University Health Sciences company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 2
[1]
Company
W
Wake Forest University Health Sciences
Related News